Methyldopa And Hydrochlorothiazide

ANDA 72510, held by Dava Pharms Inc. Hydrochlorothiazide; Methyldopa.

As of Nov 15, 2026, ANDA 72510 (Methyldopa And Hydrochlorothiazide), held by Dava Pharms Inc, was first approved by FDA on Jun 2, 1989, with 1 approved supplement and 0 published complete response letters.

First approved: Jun 2, 1989
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Jun 2, 1989	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Methyldopa And Hydrochlorothiazide50MG;500MG · tablet;oral	Hydrochlorothiazide; Methyldopa	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Apr 2, 1992	Supplement 1Labeling	Approved	None posted
Jun 2, 1989	Original application	Approved	None posted

Identifiers

Application: ANDA 72510
Drugs@FDA: Overview at FDA
Company: DAVA Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters